Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: neuroblastomaJulie R Park, Rochelle Bagatell, Wendy B London, et al.
Pediatric Blood & Cancer|January 4, 2012
Locoregional MYCN-amplified neuroblastomaAndres Morales La Madrid, Samuel Volchenboum, Julie M Gastier-Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
JCO Clinical Cancer Informatics|December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk GroupAnoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastomaOmar R Vayani, Maria E Kaufman, Kelley Moore, et al.
JCO Clinical Cancer Informatics|May 30, 2024
Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services ModuleBrian Furner, Alex Cheng, Ami V Desai, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: neuroblastomaJulie R Park, Rochelle Bagatell, Wendy B London, et al.
Pediatric Blood & Cancer|January 4, 2012
Locoregional MYCN-amplified neuroblastomaAndres Morales La Madrid, Samuel Volchenboum, Julie M Gastier-Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
JCO Clinical Cancer Informatics|December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk GroupAnoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastomaOmar R Vayani, Maria E Kaufman, Kelley Moore, et al.
JCO Clinical Cancer Informatics|May 30, 2024
Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services ModuleBrian Furner, Alex Cheng, Ami V Desai, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.
Pageof 19